Regan Lauer serves as Chief Accounting Officer at ImmunityBio Inc., a clinical-stage biotechnology company developing novel immunotherapies for cancer and infectious diseases. In this role, she oversees all aspects of the company's accounting operations, including financial reporting, SEC compliance, technical accounting, internal controls, and audit coordination. With her deep expertise in GAAP and SOX compliance, Regan ensures the accuracy and integrity of ImmunityBio's financial statements, supporting the company's mission to advance innovative treatments through robust financial governance. A Certified Public Accountant with over 20 years of experience in the life sciences sector, Regan previously held senior accounting positions at NanoString Technologies, Inc., where she managed global accounting functions during a period of rapid expansion and public company transitions, and at Omeros Corporation, contributing to financial strategy amid complex R&D investments. Earlier in her career, she worked in public accounting at Moss Adams LLP, honing her skills in audit and advisory services for biotech clients. Regan's notable achievements include leading multiple successful restatements and audit committee preparations, enhancing internal control frameworks that have fortified organizational resilience, and guiding companies through IPO readiness and mergers. Her strategic insight has been instrumental in navigating regulatory challenges, earning her recognition as a trusted leader in biotech finance.